Antithrombogenicity of UK-immobilized polymer surfaces.
D001672:Biocompatible Materials / Q000627:therapeutic use*; D002404:Catheterization / Q000295:instrumentation; D004322:Drainage / Q000295:instrumentation; D010450:Endopeptidases / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009757:Nylons; D011091:Polyesters; D011108:Polymers; D011140:Polyurethanes; D011143:Polyvinyl Chloride; D012826:Silicone Elastomers; D013499:Surface Properties; D013927:Thrombosis / Q000517:prevention & control*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use*
D001672:Biocompatible Materials; D005343:Fibrinolytic Agents; D009757:Nylons; D011091:Polyesters; D011108:Polymers; D011140:Polyurethanes; D012826:Silicone Elastomers; D011143:Polyvinyl Chloride; D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator